Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00220428
Status:
UNKNOWN
Last Update Posted:
2007-01-24
First Post:
2005-09-14
Brief Title:
T-Cell Vaccination in Multiple Sclerosis MS
Sponsor:
Sheba Medical Center
Organization:
Sheba Medical Center
Study Overview
Official Title:
The Effect of T-Cell Vaccination in Multiple Sclerosis - Phase III Safety and Efficacy Trial
Status:
UNKNOWN
Status Verified Date:
2007-01
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety of T-cell vaccination in MS patients
Detailed Description:
Immunization of MS patients with irradiated autologous encephalitogenic myelin peptides EMP specific T-cell lines or clones
Clinical immunologic and neuroradiologic evaluation
Clinical immunologic and neuroradiologic evaluation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None